Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference

ALISO VIEJO, Calif., May 3, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Bank of America Merrill Lynch Healthcare conference in Las Vegas, NV.

  • Location: Encore at the Wynn, Las Vegas, NV
  • Presentation date: Tuesday May 10, 2011
  • Presentation time: 3:40 p.m. Pacific Time

A live webcast and 30-day archive of this presentation will be available at http://www.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.

May 03, 2011